Both Tavalisse and Biktarvy offer similar effectiveness in symptom control, with the main difference being how quickly they act. Either drug is a viable option depending on the patient’s needs.

Biktarvy is gentler on the liver and kidneys and has a better safety profile for long-term use, particularly for older patients or those with pre-existing conditions.

Tavalisse has a lower risk of dependency, making it a safer option for patients concerned about addiction.

Both Tavalisse and Biktarvy are easy to use, with straightforward dosing regimens that ensure good adherence.

Both Tavalisse and Biktarvy have some contraindications based on individual health conditions, but neither has significantly more restrictions than the other.

Both drugs offer advantages depending on treatment goals. Tavalisse is great for fast relief, while Biktarvy is better for long-term management. The choice depends on the patient’s specific needs.